← back to search

Jane Mallewa

Kamuzu Central Hospital ·
Area of research
Infectious Diseases · Emergency Medicine
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, and Pneumocystis jirovecii pneumonia detection and treatment.
h-index
29
citations
2,792
works
112
NIH funding
primary concept
email

Recent publications

Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study
The Lancet Infectious Diseases 2023cited by 31position: middledoi
Genomic analysis of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli colonising adults in Blantyre, Malawi reveals previously undescribed diversity
Microbial Genomics 2023cited by 10position: middledoi
Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults
Nature Microbiology 2022cited by 44position: middledoi
Genomic and antigenic diversity of colonizing Klebsiella pneumoniae isolates mirrors that of invasive isolates in Blantyre, Malawi
Microbial Genomics 2022cited by 17position: middledoi
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies
The Lancet Global Health 2021cited by 71position: middledoi
Incidence of HIV-positive admission and inpatient mortality in Malawi (2012–2019)
AIDS 2021cited by 29position: middledoi
Spatial and Genomic Data to Characterize Endemic Typhoid Transmission
Clinical Infectious Diseases 2021cited by 28position: middledoi
Sustained Reduction in Third-generation Cephalosporin Usage in Adult Inpatients Following Introduction of an Antimicrobial Stewardship Program in a Large, Urban Hospital in Malawi
Clinical Infectious Diseases 2020cited by 42position: middledoi
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial
Clinical Infectious Diseases 2018cited by 42position: middledoi
Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study
The Lancet Infectious Diseases 2017cited by 327position: middledoi
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
New England Journal of Medicine 2017cited by 222position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicholas Feasey · London School of Hygiene & Tropical Medicine6 papers (2017–2023)Nicholas R. Thomson · University of London4 papers (2021–2023)Robert S. Heyderman · University of Liverpool4 papers (2017–2021)Eva Heinz · University of Oslo4 papers (2021–2023)Joseph M. Lewis · University of Liverpool3 papers (2022–2023) · 3 papers (2022–2023) · 3 papers (2022–2023)Mathew A. Beale · London School of Hygiene & Tropical Medicine3 papers (2022–2023)Melita A. Gordon · University of Liverpool3 papers (2017–2021)Neil Kennedy · University of London2 papers (2017–2021)Stephen B. Gordon · University of Liverpool2 papers (2021–2021)Dean Everett · Khalifa University of Science and Technology2 papers (2017–2021)Sithembile Bilima · Liverpool School of Tropical Medicine2 papers (2021–2021)Neil French · University of Liverpool2 papers (2017–2021)Clemens Masesa · University of Liverpool2 papers (2017–2021)Naor Bar‐Zeev · World Health Organization2 papers (2017–2021)Chris Jewell · University of Maryland, College Park2 papers (2020–2022)Brian Faragher · Michigan State University1 papers (2022–2022)A. Sarah Walker · Health Protection Scotland1 papers (2017–2017) · 1 papers (2017–2017)